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Abstract
Background
Colorectal endoscopic submucosal dissection (ESD) for early colorectal cancer is now covered by national 
health insurance in Japan.
Aim
To compare the clinical outcomes between endoscopic mucosal resection (EMR) and ESD in early colorectal 
cancers or adenomas with maximum diameter of 20 mm or more.
Patients and Methods
Total of 552 lesions 20 mm or larger were treated by EMR (350) or ESD (202). Short-term outcomes were 
compared between EMR and ESD. Tumor recurrence rates were investigated in patients undergoing follow-up 
for 3 months or longer.
Results
In EMR group, mean tumor diameter was 25.4 mm and en bloc resection rate 65.1%. Adverse events com-
prised postoperative bleeding in 1.7% and perforation in 0.3%. Mean procedure time was 13 minutes. Histo-
pathological diagnosis was adenoma in 70% and cancer in 30%. Tumor recurrence was seen in 4.7%.
In ESD group, mean tumor diameter was 30.5 mm and complete en bloc resection rate 91.6%. Adverse 
events were bleeding in 1.0% and perforation in 2.5%. Mean procedure time was 108 minutes. Histopathologi-
cal diagnosis of adenoma and cancer was made in 16.8% and 83.2%, respectively. Tumor recurrence was seen in 
2.2%.
Conclusion 
The results suggest that both EMR and ESD are appropriate treatment in large colon tumors of 20 mm or 
more. Appropriate therapy should be chosen by making a careful preoperative diagnosis.
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Introduction
Endoscopic mucosal resection (EMR) is considered 
standard in the treatment of colorectal tumors such as 
adenomas and cancers1-4). However, complete en bloc 
resection of tumors of greater than 20 mm is generally 
difficult. Endoscopic piecemeal mucosal resection 
(EPMR) is often performed for colorectal tumors larger 
than 20 mm5)6). However, this entails the risk of resid-
ual or local recurrence and inadequate pathological stag-
ing if the lesion is any larger6-8). Endoscopic submuco-
sal dissection (ESD) was originally developed for early 
gastric cancer, and allows en bloc resection of large 
superficial tumors9-12). The primary purpose of ESD is 
to reduce the risk of local cancer and enable an accurate 
histopathological diagnosis.
Endoscopic submucosal dissection has recently been 
reported to be useful in the treatment of superficial 
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colorectal tumors13-20). However, ESD has yet to be uni-
versally recognized as a standardized therapeutic proce-
dure for early colorectal tumors because it is difficult and 
time-consuming to perform, and is regarded as inferior 
to EMR in terms of clinical outcomes, especially risk of 
adverse events such as perforation and bleeding6)21). 
However, a number of studies have investigated indica-
tions for colorectal EMR and ESD.
In April 2012, colorectal ESD became available under 
national health insurance coverage in Japan in the treat-
ment of “…colorectal tumors diagnosed as early colorec-
tal cancer prior to treatment with a diameter of 20 to 50 
mm”. The aim of this study was to evaluate the validity 
of the indications for endoscopic treatment by comparing 
clinical outcomes between EMR and ESD in the treat-
ment of early colorectal cancers or adenomas with a 
diameter greater than or equal to 20 mm.
Patients and Methods
Between June 2007 and August 2012, 552 lesions 
greater than or equal to 20 mm were treated by EMR 
(350) or ESD (202) at Tokyo Medical University Hospi-
tal. Patient age, tumor macroscopic type, diameter, 
location, and short-term outcomes were compared 
between EMR and ESD in terms of rate of en bloc resec-
tion, procedure time, and adverse events. Preoperative 
endoscopy was performed and the lesions examined by 
magnifying chromoendoscopy to establish depth of inva-
sion. To qualify for EMR or ESD, a lesion must be 
confirmed as being non-invasive22). Recurrence rates 
were compared between 256 EMR- and 135 ESD-treated 
lesions in cases where follow-up was 3 months or longer 
(Fig. 1). Table 1 shows the types of lesion in which 
ESD was indicated in accordance with the Working 
Group of ESD Standardization for Colorectal Tumors in 
Japan. The first follow-up colonoscopy was performed 
at between 3 and 6 months after initial resection in 
patients undergoing EPMR and in those with tumors 
showing a histologically positive horizontal margin. If 
a recurrent or residual tumor was detected at the first fol-
low-up colonoscopy, a second round of surveillance 
colonoscopy was performed 6 months later, with addi-
tional endoscopic treatment ; if histologically curative 
resection was observed, however, follow-up colonoscopy 
was performed at 1 year postoperatively. All proce-
dures were performed by experienced colonoscopists (5 
staff physicians), each of whom performed more than 
1,000 colonoscopies annually.
Pit pattern diagnosis
When a lesion was detected by conventional colonos-
copy, its surface was washed with proteinase to remove 
excess mucus. Magnification was concentrated on those 
portions of the lesion where invasion appeared to have 
permeated the deepest, such as depressed areas and large 
2
1 
552 Colorectal tumors > 20 mm 
EMR: 350 lesions 
(EMR, 228; EPMR, 112) 
ESD: 202 lesions 
Short-term clinical outcome 
Follow-up period < 3 months 
 non-curative resection 
     (n = 161) 
391 colorectal tumors > 20 mm 
EMR: 256 lesions 
(EMR, 143; EPMR, 113) 
ESD: 135 lesions 
Recurrent/residual 
lesions: 15   
Fig. 1 Lesions Treated.
	 Clinical flow-chart. Among 552 colorectal tumors, 350 were treated by EMR and 202 by ESD. Of these, 391 tumors, 
including 256 treated by EMR and 135 by ESD, were followed for recurrent and/or residual lesions
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nodules6)8). The pit pattern of each lesion was initially 
assessed by magnification chromoendoscopy performed 
using 0.4% indigo-carmine (IC) dye. If this proved 
inadequate to determine the surface structure for pit pat-
tern analysis, 0.05% crystal violet was applied instead23). 
The visible pit pattern was then assessed during the 
course of the examination by the endoscopist conducting 
the procedure. This pit pattern evaluation method relied 
on the Kudo classification24) and the clinical classification 
system proposed by Fujii et al22)23).
Procedure
EMR
Endoscopic mucosal resection was performed with a 
single channel high-definition (HD) colonoscope (Olym-
pus Medical Systems Co., Ltd., Tokyo, Japan) and a 
high-frequency generator with an automatic control sys-
tem (ICC200, ERBE, Germany). It was performed 
using a snare after injecting glycerol containing a small 
amount of indigo carmine into the submucosal layer with 
a 23-gauge needle to lift the mucosa. A spiral snare, the 
Snare Master (Olympus Medical Systems Co., Ltd.) or 
the Captivator II snare (Boston Scientific Co., Tokyo, 
Japan) was used for mucosal resection. The snare was 
selected in reference to the lesion size, location, or situa-
tion. If only one piece of tissue was resected, the proce-
dure was classified as EMR, whereas if multiple pieces 
were resected, it was considered as EPMR. If the lesion 
was found to be an adenoma, EPMR was performed, 
regardless of size. If the lesion is a carcinoma classified 
as a laterally spreading tumor-granular type (LST-G) 
>20 mm and <40 mm, it is usually treated by EPMR. In 
such cases, the area including the large nodule suspected 
of being a carcinoma is resected first, followed by the 
remaining tumor suspected of being an adenoma. 
Chromo-magnification colonoscopy was used to deter-
mine whether there was any residual tumor tissue follow-
ing EMR or EPMR. A hot biopsy was also performed 
for ablative purposes where necessary. Where EPMR 
was used, all the pieces of the lesion were collected with 
net-type forceps.
ESD
Endoscopic submucosal dissection was performed 
with a single-channel HD colonoscope (Olympus Medi-
cal Systems Co., Ltd.). When the lesion was located in 
the rectum or proximal colon, a Q260J endoscope 
(Olympus Optical, Tokyo, Japan) was the most fre-
quently used. A PCF-Q260JI endoscope (Olympus 
Optical) was used for lesions located in the distal colon. 
Endoscopic submucosal dissection was performed using 
a high-frequency generator with the same automatic con-
trol system as used with EMR. An attachment hood 
was used in all procedures. The injection solutions 
were glycerol and hyaluronic acid (MucoUp® ; Johnson 
& Johnson, New Brunswick, NJ, USA) with a small 
amount of indigo carmine. After saline injection, cir-
cumferential incision and dissection were performed. A 
Ball-tip B knife (Zeon Medical Inc., Tokyo, Japan), bipo-
lar knife or Dual Knife (Olympus Medical Systems Co., 
Ltd.), or monopolar knife for circumferential incision and 
dissection were used. A carbon dioxide (CO2) insuffla-
tion system was used in all patients, which was essential 
for reducing abdominal discomfort25)26).
Sedation
The sedative agents flunitrazepam or midazolam were 
used in all patients undergoing ESD. These agents were 
intravenously administered initially at the generally rec-
ommended doses : 0.006 mg/kg for flunitrazepam, and 
0.05 mg/kg for midazolam. An additional 1 or 2 mg 
was given repeatedly as needed based on the endosco-
pist’s judgment. No sedation was usually given in 
patients undergoing EMR.
Histological assessment
All the resected specimens were cut into 2-mm slices 
and examined microscopically for histological type, 
depth of invasion, and lateral and vertical resection mar-
gins. En bloc resection was defined as one-piece resec-
tion of an entire lesion as observed endoscopically. A 
curative resection was achieved when both the lateral and 
vertical margins of the specimen were free of cancer and 
there was no submucosal invasion deeper than 1,000 μm 
from the muscularis mucosae, no lymphatic invasion, no 
3
Table 1 Indications for ESD
1.  Large-sized lesions of > 20 mm in diameter, in which en bloc resection using snare 
EMR is difficult, although indicated for endoscopic treatment 
・LST-NG, particularly pseudo-depressed type
・Lesions showing VI type pit pattern by Kudo classification
・Carcinoma with submucosal infiltration 
・Large depressed-type lesion
・Large elevated lesion suspected to be carcinoma
2. Mucosal lesions with fibrosis caused by prolapse due to biopsy or peristalsis
3. Local residual early carcinoma after endoscopic resection
ESD, endoscopic submucosal dissection
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vascular involvement, no budding, or no poorly differen-
tiated component27). Histological diagnoses were based 
on the Japanese classification of cancer of the colon and 
rectum28). Lesions were thus classified as adenoma, 
intramucosal carcinoma, carcinoma with slight submuco-
sal invasion (less than 1,000 μm ; SM-s), or carcinoma 
with deep submucosal invasion (greater than 1,000 μm ; 
SM-d).
Statistical analysis
All values are reported as the mean ± standard devia-
tion where applicable. The t test for continuous vari-
ables and χ2 test for dichotomous variables were used to 
compare the baseline characteristics between the two 
groups. All statistical analyses were performed using 
SPSS version 15.0 (SPSS Inc.). The P-values were 
2-sided ; a P-value of less than 0.05 indicated a statisti-
cally significant difference.
Results
Clinicopathological features of patients and colorec-
tal lesions (Table 2)
The clinical characteristics of the patients in each 
group are shown in Table 2. No statistically significant 
difference was observed between the two groups in terms 
of mean age or follow-up period. Tumor size was sig-
nificantly larger in the ESD than in the EMR group. In 
terms of macroscopic type, the proportion of lateral 
spreading non-granular (LST-NG) type tumors was sig-
nificantly higher in the ESD group. The VI pit pattern 
was significantly higher in the ESD group.
En bloc and curative resection rates (Table 3)
En bloc resection was performed in 228 out of 350 
lesions (65.1%) in the EMR group, and in 185 out of 202 
lesions (91.6%) in the ESD group. The en bloc resec-
tion rate was significantly higher in the ESD group.
Curative resection was performed in 196 out of 348 
lesions (56.6%) in the EMR group and in 165 out of 202 
lesions (81.7%) in the ESD group. The curative resec-
tion rate was significantly higher in the ESD group.
Procedure time (Table 3)
The median procedure time was in the ESD group (108 
min) was significantly longer than that in the EMR group 
(13 min) (P < 0.001).
Adverse events (Table 3)
Perforation occurred in 1 case (0.3%) in the EMR 
group and in 5 cases (2.6%) in the ESD group. It was 
significantly higher in the ESD group. However, these 
cases could be managed with conservative therapy.
Minor delayed bleeding occurred in 2 cases (1.0%) in 
the ESD group and 6 (1.7%) cases in the EMR group (P 
4
Table 2 Clinical characteristics of patients and tumors
EMR (n = 350) ESD (n = 202) P-value
Mean age ± SD (year) 68.1 ± 12.3 69.3 ± 10.4 NS
Tumor size ± SD (mm) 25.4 ± 7.8
20-50 mm : 347
<50 : 3
30.5 ± 12.3
20-50 mm : 169
<50 : 23
<0.05
Location
 Right colon
 Left colon
 Rectum
165 (47.2%)
 89 (25.4%)
 96 (27.4%)
101 (50.0%)
 38 (18.8%)
 63 (31.2%)
NS
<0.05
NS
Median follow-up (month) 38.2 ± 15.4 40.6 ± 7.0 NS
Macroscopic type
 Is/Isp
 IIc
 LST-NG
 LST-G
 Residual lesion
 98 (28.0%)
 1 (0.3%)
 51 (14.6%)
199 (56.8%)
 1 (0.3%)
13 (6.4%)
 2 (1.0%)
 90 (44.6%)
 95 (47.0%)
 2 (1.0%)
<0.01
NS
<0.01
<0.01
NS
Pit pattern
 II
 IIIL
 IIIs
 IV
 VI
 8 (2.3%)
289 (82.6%)
25 (7.1%)
212 (3.4%)
 16 (4.6%)
 0 
 90 (44.6%)
 44 (21.8%)
20 (9.9%)
48 (2.7%)
<0.01
<0.01
<0.01
<0.01
<0.01
EMR ; endoscopic mucosal resection, ESD ; endoscopic submucosal dissection
LST-NG ; laterally-spreading tumor-non-granular type, LST-G ; laterally-spreading tumor-granular type
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= 0.493). However, all cases were successfully man-
aged conservatively using endoclips, with no blood trans-
fusions or additional procedures necessary.
Histopathological diagnosis (Table 4)
Histopathological diagnoses were adenoma in 70.0% 
of the EMR group and cancer in 83.2% of the ESD 
group. A significantly higher rate of SM invasion was 
observed in the ESD group (P < 0.05). No statistically 
significant difference was observed in lymphovascular 
invasion between the two groups.
Residual/recurrent lesions (Table 5)
There were 12 cases (4.7%) of local recurrence in the 
EMR group during a mean endoscopic follow-up period 
of 40.6 ± 7.0 months. In comparison, local recurrence 
occurred in 3 cases (2.2%) in the ESD group during a 
mean endoscopic follow-up period of 38.2 ± 15.4 
months.
The macroscopic types of residual/recurrent lesions 
were Is and LST-G in the EMR group. There were 3 
residual LST-NG lesions in the ESD group. All local 
recurrent lesions were treated by piecemeal resection. 
Tumor size prior to treatment was 42.5 ± 9.8 mm in the 
EMR group and 41.8 ± 8.6 mm in the ESD group. The 
number of resected specimens was greater than 5 in both 
groups. Curative resection was achieved in all residual 
or recurrent lesions after 1 additional endoscopic treat-
ment.
Discussion
The purpose of this study was to assess the validity of 
indications for endoscopic treatment by comparing clini-
cal outcomes between EMR and ESD for tumors larger 
than 20 mm. The final pathological diagnosis revealed 
many adenomas in the EMR group and many cancer 
lesions in the ESD group. Preoperative magnification 
endoscopy was used in evaluating the lesions. We 
believe that using preoperative magnification endoscopy 
allowed us to choose the most appropriate therapeutic 
option.
Preoperative evaluation of depth of invasion appears 
crucial. High magnification pit pattern analysis is use-
ful in predicting deep submucosal invasion in colorectal 
tumors. The pit pattern of colorectal tumors is gener-
ally categorized according to the Kudo classification sys-
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Table 3 Short-term clinical outcomes
EMR (n = 350) ESD (n = 202) P-value
En bloc resection 228 (65.1%) 185 (91.6%) < 0.01
Complete resection 198 (56.6%) 165 (81.7%) < 0.01
Procedure time (minute) 13 108 < 0.01
Adverse events
 Perforation
 Delayed bleeding
 1 (0.3%)
 6 (1.7%)
 5 (2.5%)
 2 (1.0%)
< 0.05
NS
EMR ; endoscopic mucosal resection, ESD ; endoscopic submucosal dissection
Table 4 Results of resected specimens
EMR (n = 350) ESD (n = 202) P-value
Histopathology
 Adenoma
 Well-differentiated
 Moderately-differentiated
245 (70.0%)
100 (28.6%)
 5 (1.4%)
234 (16.8%)
148 (73.3%)
20 (9.9%)
<0.01
<0.01
<0.01
Depth of cancer tumor
 Intramucosa
 Submucosa
  SM-s
  SM-d
100 (28.6%)
 5 (1.4%)
 4 (1.1%)
 1 (0.3%)
146 (16.8%)
 22 (10.9%)
15 (7.4%)
 7 (3.5%)
<0.05
<0.05
Lymphatic-vascular invasion
 Lymphatic invasion
 Vascular invasion
 1 (0.3%)
0 
 5 (2.5%)
 3 (1.5%)
NS
–
EMR ; endoscopic mucosal resection, ESD ; endoscopic submucosal dissection
SM-s ; Submucosal slight invasion (≥1,000 μm)
SM-d ; Submucosal deep invasion (<1,000 μm)
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tem29), which allows histological grade and invasion 
depth to be determined. In this system, a type II pit pat-
tern indicates a hyperplastic polyp or superficial-type 
serrated adenoma and sessile serrated adenoma or polyp 
(SSA/P) ; type IIIL primarily indicates an adenoma with 
mild-to-moderate atypia ; type IIIS is characteristic of a 
depressed lesion and primarily indicates a tubular 
adenoma ; type IV is observed in large, protruded, nod-
ule-aggregated type lesions, and represents a tubulovil-
lous adenoma and mucosal carcinoma in many cases. 
The type V pit pattern is further classified into type VI, 
tumors, characterized by an irregular glandular structure, 
and type VN, tumors, which have a clear amorphous area. 
Type VI is most likely to be an adenoma with severe 
atypia or submucosal invasive carcinoma, while type VN 
is an index for carcinoma with deep submucosal inva-
sion30). In the present study, the VI pit pattern was sig-
nificantly higher in the ESD group. The lesions 
described in Table 1 were likely to be cancerous, indicat-
ing ESD. Therefore, we believe that the appropriate 
preoperative diagnoses were made.
Endoscopic mucosal resection is indicated in the treat-
ment of superficial, early-stage colorectal cancer as it is 
minimally invasive and offers excellent results in terms 
of clinical outcome1)3). However, conventional EMR 
techniques for resection of LSTs31)32) are inadequate for 
en bloc resection of flat lesions larger or equal to 20 mm, 
as there is the risk of incomplete removal and problems 
with local recurrence33). Conventional EMR usually 
results in EPMR, particularly for large LSTs ≥20 mm, 
with reports of local recurrence rates ranging from 7.4% 
to 17%7)33)34). Most of these recurrences, however, 
receive repeated endoscopic treatment with excellent 
results regarding preservation of the colorectum. How-
ever, only a few cases required surgery after EPMR in a 
long-term follow-up study6). Those cases may have 
originally involved either submucosal or lymphatic inva-
sion not diagnosed histologically due to the increased 
difficulty involved in assessing piecemeal resection.
No recurrence of invasive (submucosal) cancer was 
observed in the present study. However, some recur-
rence of adenoma or intramucosal cancer was observed 
in the EMR and ESD groups when piecemeal resection (5 
or more pieces) was performed in lesions of 40 mm or 
larger. Tumors of 40 mm or larger can often completely 
cover a haustrum, and occasionally exceed half the lumen 
of the colon. Such tumors are very difficult to treat 
endoscopically. In an earlier study, removal of 5 or 
more pieces was found to constitute an independent risk 
factor for local recurrence after EPMR35). This suggests 
that even though piecemeal resection of LST-G tumors 
of 40 mm or more is possible, it should only be selected 
when the location of the lesion allows sufficient maneu-
verability to keep the number of pieces to a minimum.
The primary advantage of ESD over EMR is a higher 
en bloc resection rate in large colonic tumors, those in 
which fibrosis has led to a positive result for the non-lift-
ing sign, or those that have already undergone surgical 
procedures. Additional surgical resection is sometimes 
required after endoscopic resection for SM invasive can-
cer. However, after the introduction of ESD, additional 
surgery for adenomas or intramucosal and SM-s cancers 
has only been required in 1% of such cases, which is a 
significantly lower figure than the 20% rate for such sur-
6
Table 5 Residual/recurrent lesions after endoscopic resection
EMR : 12 (4.7%) ESD : 3 (2.2%) 
Macroscopic type Is : 2
LST-G : 10
LST-NG : 3
 
Location
 Right colon
 Left colon
 Rectum
3 (1.8%)
8 (8.9%)
1 (1.0%)
1 (1.0%)
2 (16.5%)
–
Tumor size prior to treatment  ± SD (mm) 42.5 ± 9.8 41.8 ± 8.6
Number of resected specimens <5 : 12 <5 : 3
Tumor size of residual/recurrent lesion ± SD (mm)  7.5 ± 3.3  8.2 ± 6.0
Additional treatment time 1 1
Additional treatment EMR : 4
Hot biopsy : 8
EMR : 2
Hot biopsy : 1
Histopathology of residual/ recurrent lesion Adenoma : 12 Adenoma : 1
Carcinoma : 2
EMR ; endoscopic mucosal resection, ESD ; endoscopic submucosal dissection
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geries before the introduction of ESD36). However, sur-
gery time is longer and the incidence of complications is 
significantly higher than with EMR. It is better to select 
ESD according to the results of a careful preoperative 
diagnosis.
It is crucial to establish depth of invasion preopera-
tively. In the present study, this was done by using 
magnifying chromoendoscopy. However, one study 
found that diagnostic performance with this approach 
was inferior in protruded-type lesions compared with the 
flat or depressed type37). Therefore, large lesions show-
ing the potential for submucosal invasion at preoperative 
examination should be resected using the appropriate 
endoscopic procedures, with the aim of en bloc removal 
or fractionation into only a few pieces. If the aforemen-
tioned endoscopic techniques should prove unfeasible, 
surgical laparoscopy would be an appropriate alternative 
treatment strategy.
One limitation of this study was that it was not a ran-
domized controlled trial. It is necessary, therefore, to 
prospectively compare clinical outcomes between ESD 
and EMR in large colorectal tumors in future study. 
Another limitation of this study was that 30% of the total 
EMR and EPMR cases had to be excluded from the anal-
ysis as follow-up colonoscopy was either performed 
elsewhere or further data regarding such results were 
unavailable.
In conclusion, the present results suggest that both 
EMR and ESD are appropriate treatment in large colon 
tumors of 20 mm or more. Good clinical outcomes 
were obtained by selectively using witch treatment. It 
may be possible to distinguish EMR and ESD by careful 
preoperative diagnosis.
To this end, appropriate therapy should be chosen by 
making a careful preoperative morphological diagnosis 
and by thoroughly assessing the degree of malignancy as 
well as invasion depth using the pit pattern-based diag-
nostic procedure.
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大腸 ESD と EMR の治療成績の比較検討
佐　藤　丈　征　　　福　澤　誠　克　　　後藤田　卓　志 
森　安　史　典
東京医科大学消化器内科学分野
【要旨】【背景】　大腸の『最大径が 2 cmから 5 cmの早期癌又は腺腫』に対して内視鏡的粘膜下層剥離術（ESD）が
保険適応となった。しかし ESDは、その難易度の高さから手技の標準化されておらず、多くの研究で EMRと ESD
の比較検討が行われている。
【目的】　2 cm以上 5 cm以下の早期癌又は腺腫に対して行われた大腸 EMR/ESDの治療成績を比較検討する。
【対象と方法】　2007年 6月から 2012年 8月までに 2 cm以上の大腸腫瘍性病変に対して内視鏡切除（EMR/ESD）を
行った 552病変（EMR : 350病変、ESD : 202病変）の短期治療成績を比較検討した。また 3ヶ月以上経過観察が可
能だった病変を対象とし、遺残再発率ついて検討した。
【結果】
　EMR
　平均腫瘍径は 25.4±7.8 mm、一括切除率は 65.1%であり、偶発症は後出血 6例（1.7%）、穿孔は 1例（0.3%）だった。
平均治療時間は 13分だった。組織診断は腺腫 : 70%、癌 : 30%だった。遺残再発は 12例（4.7%）であった。
　ESD 
　平均腫瘍径は 30.5±12.3 mm、一括切除率は 91.6%であり、偶発症は後出血 2例（1.0%）、穿孔は 5例（2.5%）であっ
た。平均治療時間は平均 108分だった。組織診断は腺腫 : 16.8%、癌 : 83.2%だった。遺残再発は 3例（2.2%）であっ
た。
【結論】　EMR、ESDとも 20 mm以上の大腸腫瘍に対する加療として適切な方法であり、両加療法を使い分けること
により良好な加療結果が期待できる。大腸腫瘍に対する内視鏡的治療は、慎重な術前診断を行った上で適切な術式
を選択することが望ましいと思われた。
〈キーワード〉　内視鏡的粘膜切除術、内視鏡的粘膜下層剥離術、拡大内視鏡
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